BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Graichen R, Xu X, Braam SR, Balakrishnan T, Norfiza S, Sieh S, Soo SY, Tham SC, Mummery C, Colman A. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation. 2008;76:357-370. [PMID: 18021257 DOI: 10.1111/j.1432-0436.2007.00236.x] [Cited by in Crossref: 186] [Cited by in F6Publishing: 152] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Pasumarthi KB. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. BioDrugs 2008;22:361-74. [PMID: 18998754 DOI: 10.2165/0063030-200822060-00003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
2 Chow M, Boheler KR, Li RA. Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Res Ther 2013;4:97. [PMID: 23953772 DOI: 10.1186/scrt308] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gong R, Jiang Z, Zagidullin N, Liu T, Cai B. Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration. Signal Transduct Target Ther 2021;6:31. [PMID: 33500391 DOI: 10.1038/s41392-020-00413-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010;90:1507-46. [PMID: 20959622 DOI: 10.1152/physrev.00054.2009] [Cited by in Crossref: 448] [Cited by in F6Publishing: 405] [Article Influence: 40.7] [Reference Citation Analysis]
5 Fritsch MK, Singer DB. Embryonic stem cell biology. Adv Pediatr 2008;55:43-77. [PMID: 19048727 DOI: 10.1016/j.yapd.2008.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Kempf H, Lecina M, Ting S, Zweigerdt R, Oh S. Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells. Stem Cell Res. 2011;7:198-209. [PMID: 21907163 DOI: 10.1016/j.scr.2011.06.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
7 Bernstein HS, Hyun WC. Strategies for enrichment and selection of stem cell-derived tissue precursors. Stem Cell Res Ther 2012;3:17. [PMID: 22575029 DOI: 10.1186/scrt108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Vidarsson H, Hyllner J, Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev Rep 2010;6:108-20. [PMID: 20091143 DOI: 10.1007/s12015-010-9113-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
9 Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc 2013;8:162-75. [PMID: 23257984 DOI: 10.1038/nprot.2012.150] [Cited by in Crossref: 783] [Cited by in F6Publishing: 673] [Article Influence: 87.0] [Reference Citation Analysis]
10 Rajala K, Pekkanen-Mattila M, Aalto-Setälä K. Cardiac differentiation of pluripotent stem cells. Stem Cells Int 2011;2011:383709. [PMID: 21603143 DOI: 10.4061/2011/383709] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
11 Pushp P, Nogueira DES, Rodrigues CAV, Ferreira FC, Cabral JMS, Gupta MK. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. Stem Cell Rev Rep 2021;17:748-76. [PMID: 33098306 DOI: 10.1007/s12015-020-10061-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Atkinson SP, Lako M, Armstrong L. Potential for pharmacological manipulation of human embryonic stem cells. Br J Pharmacol 2013;169:269-89. [PMID: 22515554 DOI: 10.1111/j.1476-5381.2012.01978.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
13 Xu XQ, Soo SY, Sun W, Zweigerdt R. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 2009;27:2163-74. [PMID: 19658189 DOI: 10.1002/stem.166] [Cited by in Crossref: 114] [Cited by in F6Publishing: 105] [Article Influence: 9.5] [Reference Citation Analysis]
14 Kuijk E, Geijsen N, Cuppen E. Pluripotency in the light of the developmental hourglass: Pluripotency and the developmental hourglass. Biol Rev 2015;90:428-43. [DOI: 10.1111/brv.12117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
15 Pekkanen-Mattila M, Kerkelä E, Tanskanen JM, Pietilä M, Pelto-Huikko M, Hyttinen J, Skottman H, Suuronen R, Aalto-Setälä K. Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines. Ann Med. 2009;41:360-370. [PMID: 19165643 DOI: 10.1080/07853890802609542] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
16 Liu BH, Yeh HY, Lin YC, Wang MH, Chen DC, Lee BH, Hsu SH. Spheroid formation and enhanced cardiomyogenic potential of adipose-derived stem cells grown on chitosan. Biores Open Access 2013;2:28-39. [PMID: 23514754 DOI: 10.1089/biores.2012.0285] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
17 Barruet E, Hadadeh O, Peiretti F, Renault VM, Hadjal Y, Bernot D, Tournaire R, Negre D, Juhan-Vague I, Alessi MC, Binétruy B. p38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells. Stem Cells Dev 2011;20:1233-46. [PMID: 20954847 DOI: 10.1089/scd.2010.0213] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
18 Bernstein HS. Cardiac repair and restoration using human embryonic stem cells. Regenerative Medicine 2012;7:697-712. [DOI: 10.2217/rme.12.46] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
19 Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. 2009;2:198-210. [PMID: 19393593 DOI: 10.1016/j.scr.2009.02.002] [Cited by in Crossref: 287] [Cited by in F6Publishing: 240] [Article Influence: 23.9] [Reference Citation Analysis]
20 Wu J, Kubota J, Hirayama J, Nagai Y, Nishina S, Yokoi T, Asaoka Y, Seo J, Shimizu N, Kajiho H, Watanabe T, Azuma N, Katada T, Nishina H. p38 Mitogen-Activated Protein Kinase Controls a Switch Between Cardiomyocyte and Neuronal Commitment of Murine Embryonic Stem Cells by Activating Myocyte Enhancer Factor 2C-Dependent Bone Morphogenetic Protein 2 Transcription. Stem Cells and Development 2010;19:1723-34. [DOI: 10.1089/scd.2010.0066] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
21 Zweigerdt R, Olmer R, Singh H, Haverich A, Martin U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc. 2011;6:689-700. [PMID: 21527925 DOI: 10.1038/nprot.2011.318] [Cited by in Crossref: 203] [Cited by in F6Publishing: 166] [Article Influence: 20.3] [Reference Citation Analysis]
22 Dick E, Rajamohan D, Ronksley J, Denning C. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem Soc Trans 2010;38:1037-45. [PMID: 20659000 DOI: 10.1042/BST0381037] [Cited by in Crossref: 87] [Cited by in F6Publishing: 37] [Article Influence: 7.9] [Reference Citation Analysis]
23 Philonenko ES, Shutova MV, Chestkov IV, Lagarkova MA, Kiselev SL. Current progress and potential practical application for human pluripotent stem cells. Int Rev Cell Mol Biol. 2011;292:153-196. [PMID: 22078961 DOI: 10.1016/b978-0-12-386033-0.00004-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Laco F, Lam AT, Woo TL, Tong G, Ho V, Soong PL, Grishina E, Lin KH, Reuveny S, Oh SK. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor. Stem Cell Res Ther 2020;11:118. [PMID: 32183888 DOI: 10.1186/s13287-020-01618-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
25 Gao M, Yang J, Wei R, Liu G, Zhang L, Wang H, Wang G, Gao H, Chen G, Hong T. Ghrelin induces cardiac lineage differentiation of human embryonic stem cells through ERK1/2 pathway. Int J Cardiol 2013;167:2724-33. [PMID: 22809535 DOI: 10.1016/j.ijcard.2012.06.106] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
26 Xie M, Cao N, Ding S. Small molecules for cell reprogramming and heart repair: progress and perspective. ACS Chem Biol. 2014;9:34-44. [PMID: 24372513 DOI: 10.1021/cb400865w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
27 Xu XQ, Graichen R, Soo SY, Balakrishnan T, Rahmat SN, Sieh S, Tham SC, Freund C, Moore J, Mummery C. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation. 2008;76:958-970. [PMID: 18557764 DOI: 10.1111/j.1432-0436.2008.00284.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 119] [Article Influence: 11.0] [Reference Citation Analysis]
28 Lam AT, Chen AK, Li J, Birch WR, Reuveny S, Oh SK. Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture. Stem Cell Res Ther 2014;5:110. [PMID: 25223792 DOI: 10.1186/scrt498] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
29 Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S, Kadota S, Morone N, Barve M, Asai Y, Tenkova-Heuser T, Heuser JE, Uesugi M, Aiba K, Nakatsuji N. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2012;2:1448-1460. [PMID: 23103164 DOI: 10.1016/j.celrep.2012.09.015] [Cited by in Crossref: 182] [Cited by in F6Publishing: 145] [Article Influence: 20.2] [Reference Citation Analysis]
30 Mahmood A, Harkness L, Schrøder HD, Abdallah BM, Kassem M. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 2010;25:1216-33. [PMID: 20200949 DOI: 10.1002/jbmr.34] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 7.1] [Reference Citation Analysis]
31 Liu J, Zhang Z, Liu Y, Guo C, Gong Y, Yang S, Ma M, Li Z, Gao WQ, He Z. Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells. Stem Cells Dev 2012;21:2095-110. [PMID: 22428725 DOI: 10.1089/scd.2012.0031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
32 Bouchard F, Paquin J. Differential effects of retinoids and inhibitors of ERK and p38 signaling on adipogenic and myogenic differentiation of P19 stem cells. Stem Cells Dev 2013;22:2003-16. [PMID: 23441952 DOI: 10.1089/scd.2012.0209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Lee JA, An J, Kang TM, De D, Kim KK. Discovery of Natural Compounds Promoting Cardiomyocyte Differentiation. Stem Cells Dev 2019;28:13-27. [PMID: 30358491 DOI: 10.1089/scd.2018.0153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
34 David R, Jarsch VB, Schwarz F, Nathan P, Gegg M, Lickert H, Franz WM. Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell. Cardiovasc Res 2011;92:115-22. [PMID: 21632880 DOI: 10.1093/cvr/cvr158] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
35 Evans T. Embryonic Stem Cells as a Model for Cardiac Development and Disease. Drug Discov Today Dis Models 2008;5:147-55. [PMID: 19802368 DOI: 10.1016/j.ddmod.2009.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
36 Sirabella D, Cimetta E, Vunjak-Novakovic G. "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells. Exp Biol Med (Maywood) 2015;240:1008-18. [PMID: 26069271 DOI: 10.1177/1535370215589910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
37 Jiang Y, Lian XL. Heart regeneration with human pluripotent stem cells: Prospects and challenges. Bioact Mater 2020;5:74-81. [PMID: 31989061 DOI: 10.1016/j.bioactmat.2020.01.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
38 Ng K, Lee Y, Chan Y, Lai W, Fung M, Li RA, Siu C, Tse H. Exogenous expression of HIF-1α promotes cardiac differentiation of embryonic stem cells. Journal of Molecular and Cellular Cardiology 2010;48:1129-37. [DOI: 10.1016/j.yjmcc.2010.01.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
39 Yuan X, Li W, Ding S. Small molecules in cellular reprogramming and differentiation. Prog Drug Res 2011;67:253-66. [PMID: 21141734 DOI: 10.1007/978-3-7643-8989-5_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
40 Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012;111:344-358. [PMID: 22821908 DOI: 10.1161/CIRCRESAHA.110.227512] [Cited by in Crossref: 438] [Cited by in F6Publishing: 236] [Article Influence: 48.7] [Reference Citation Analysis]
41 Wei H, Tan G, Manasi, Qiu S, Kong G, Yong P, Koh C, Ooi TH, Lim SY, Wong P, Gan SU, Shim W. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells.Stem Cell Res. 2012;9:87-100. [PMID: 22683798 DOI: 10.1016/j.scr.2012.04.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
42 Elliott DA, Braam SR, Koutsis K, Ng ES, Jenny R, Lagerqvist EL, Biben C, Hatzistavrou T, Hirst CE, Yu QC. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods. 2011;8:1037-1040. [PMID: 22020065 DOI: 10.1038/nmeth.1740] [Cited by in Crossref: 294] [Cited by in F6Publishing: 262] [Article Influence: 29.4] [Reference Citation Analysis]
43 Ou DB, Zeng D, Jin Y, Liu XT, Teng JW, Guo WG, Wang HT, Su FF, He Y, Zheng QS. The long-term differentiation of embryonic stem cells into cardiomyocytes: an indirect co-culture model. PLoS One 2013;8:e55233. [PMID: 23383121 DOI: 10.1371/journal.pone.0055233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
44 Wobus AM, Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol 2011;85:79-117. [PMID: 21225242 DOI: 10.1007/s00204-010-0641-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 70] [Article Influence: 10.5] [Reference Citation Analysis]
45 Phillips BW, Horne R, Lay TS, Rust WL, Teck TT, Crook JM. Attachment and growth of human embryonic stem cells on microcarriers. Journal of Biotechnology 2008;138:24-32. [DOI: 10.1016/j.jbiotec.2008.07.1997] [Cited by in Crossref: 126] [Cited by in F6Publishing: 103] [Article Influence: 9.7] [Reference Citation Analysis]
46 Schade D, Plowright AT. Medicinal Chemistry Approaches to Heart Regeneration. J Med Chem 2015;58:9451-79. [DOI: 10.1021/acs.jmedchem.5b00446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
47 Kochegarov A. Small molecules for stem cells. Expert Opin Ther Pat 2009;19:275-81. [PMID: 19441903 DOI: 10.1517/13543770802709010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
48 Wang J, Xia Y. Assessing developmental roles of MKK4 and MKK7 in vitro. Commun Integr Biol 2012;5:319-24. [PMID: 23060952 DOI: 10.4161/cib.20216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
49 Besser RR, Ishahak M, Mayo V, Carbonero D, Claure I, Agarwal A. Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes. Theranostics 2018;8:124-40. [PMID: 29290797 DOI: 10.7150/thno.19441] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
50 Tran TH, Wang X, Browne C, Zhang Y, Schinke M, Izumo S, Burcin M. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells. 2009;27:1869-1878. [PMID: 19544447 DOI: 10.1002/stem.95] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 9.0] [Reference Citation Analysis]
51 Brenner C, Franz WM. The use of stem cells for the repair of cardiac tissue in ischemic heart disease. Expert Rev Med Devices 2011;8:209-25. [PMID: 21381911 DOI: 10.1586/erd.10.78] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
52 Bouchard F, Paquin J. Skeletal and cardiac myogenesis accompany adipogenesis in P19 embryonal stem cells. Stem Cells Dev 2009;18:1023-32. [PMID: 19012474 DOI: 10.1089/scd.2008.0288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
53 Seo HH, Lee CY, Lee J, Lim S, Choi E, Park JC, Lee S, Hwang KC. The role of nuclear factor of activated T cells during phorbol myristate acetate-induced cardiac differentiation of mesenchymal stem cells. Stem Cell Res Ther 2016;7:90. [PMID: 27405982 DOI: 10.1186/s13287-016-0348-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Wong SS, Bernstein HS. Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. Regen Med 2010;5:763-75. [PMID: 20868331 DOI: 10.2217/rme.10.52] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
55 Smits AM, van Oorschot AA, Goumans MJ. Isolation and differentiation of human cardiomyocyte progenitor cells into cardiomyocytes. Methods Mol Biol 2012;879:339-49. [PMID: 22610569 DOI: 10.1007/978-1-61779-815-3_20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
56 Hanson KP, Jung JP, Tran QA, Hsu SP, Iida R, Ajeti V, Campagnola PJ, Eliceiri KW, Squirrell JM, Lyons GE, Ogle BM. Spatial and temporal analysis of extracellular matrix proteins in the developing murine heart: a blueprint for regeneration. Tissue Eng Part A 2013;19:1132-43. [PMID: 23273220 DOI: 10.1089/ten.TEA.2012.0316] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
57 Kim HJ, Kim MH, Kim JT, Lee WJ, Kim E, Lim KS, Kim JK, Yang YI, Park KD, Kim YH. Intracellular transduction of TAT-Hsp27 fusion protein enhancing cell survival and regeneration capacity of cardiac stem cells in acute myocardial infarction. J Control Release 2015;215:55-72. [PMID: 26232724 DOI: 10.1016/j.jconrel.2015.07.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kempf H, Zweigerdt R. Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules. Adv Biochem Eng Biotechnol 2018;163:39-69. [PMID: 29071404 DOI: 10.1007/10_2017_30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
59 Low JL, Jürjens G, Seayad J, Seow J, Ting S, Laco F, Reuveny S, Oh S, Chai CL. Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells. Bioorg Med Chem Lett 2013;23:3300-3. [PMID: 23602399 DOI: 10.1016/j.bmcl.2013.03.103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
60 Olmer R, Martin U. Induced Pluripotent Stem Cells Differentiate into Functional Cardiomyocytes. In: Hayat M, editor. Stem Cells and Cancer Stem Cells, Volume 12. Dordrecht: Springer Netherlands; 2014. pp. 47-62. [DOI: 10.1007/978-94-017-8032-2_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Rungarunlert S, Klincumhom N, Tharasanit T, Techakumphu M, Pirity MK, Dinnyes A. Slow turning lateral vessel bioreactor improves embryoid body formation and cardiogenic differentiation of mouse embryonic stem cells. Cell Reprogram 2013;15:443-58. [PMID: 24020697 DOI: 10.1089/cell.2012.0082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
62 Davies SG, Kennewell PD, Russell AJ, Seden PT, Westwood R, Wynne GM. Stemistry: the control of stem cells in situ using chemistry. J Med Chem 2015;58:2863-94. [PMID: 25590360 DOI: 10.1021/jm500838d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
63 Haraguchi Y, Matsuura K, Shimizu T, Yamato M, Okano T. Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering. J Tissue Eng Regen Med. 2015;9:1363-1375. [PMID: 23728860 DOI: 10.1002/term.1761] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
64 Kaul H, Ventikos Y. Investigating biocomplexity through the agent-based paradigm. Brief Bioinform 2015;16:137-52. [PMID: 24227161 DOI: 10.1093/bib/bbt077] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
65 Dierickx P, Doevendans PA, Geijsen N, van Laake LW. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair. J Cardiovasc Transl Res 2012;5:566-80. [PMID: 22806916 DOI: 10.1007/s12265-012-9391-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
66 Xu X, Zweigerdt R, Soo S, Ngoh Z, Tham S, Wang S, Graichen R, Davidson B, Colman A, Sun W. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 2008;10:376-89. [DOI: 10.1080/14653240802105307] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
67 Braam SR, Passier R, Mummery CL. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 2009;30:536-45. [PMID: 19762090 DOI: 10.1016/j.tips.2009.07.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
68 Ritner C, Wong SS, King FW, Mihardja SS, Liszewski W, Erle DJ, Lee RJ, Bernstein HS. An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLoS One 2011;6:e16004. [PMID: 21245908 DOI: 10.1371/journal.pone.0016004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
69 Jara-Avaca M, Kempf H, Rückert M, Robles-Diaz D, Franke A, de la Roche J, Fischer M, Malan D, Sasse P, Solodenko W, Dräger G, Kirschning A, Martin U, Zweigerdt R. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival. Stem Cell Reports 2017;8:305-17. [PMID: 28089668 DOI: 10.1016/j.stemcr.2016.12.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
70 Laco F, Low JL, Seow J, Woo TL, Zhong Q, Seayad J, Liu Z, Wei H, Reuveny S, Elliott DA, Chai CL, Oh SK. Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling. J Mol Cell Cardiol 2015;80:56-70. [PMID: 25528965 DOI: 10.1016/j.yjmcc.2014.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
71 Lim DY, Ng YH, Lee J, Mueller M, Choo AB, Wong VV. Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells. J Biotechnol 2011;153:77-85. [PMID: 21458505 DOI: 10.1016/j.jbiotec.2011.03.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
72 Konze SA, Werneburg S, Oberbeck A, Olmer R, Kempf H, Jara-avaca M, Pich A, Zweigerdt R, Buettner FFR. Proteomic Analysis of Human Pluripotent Stem Cell Cardiomyogenesis Revealed Altered Expression of Metabolic Enzymes and PDLIM5 Isoforms. J Proteome Res 2017;16:1133-49. [DOI: 10.1021/acs.jproteome.6b00534] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
73 Xu C, Police S, Hassanipour M, Li Y, Chen Y, Priest C, O’Sullivan C, Laflamme MA, Zhu WZ, Van Biber B. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen Med. 2011;6:53-66. [PMID: 21175287 DOI: 10.2217/rme.10.91] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
74 Batalov I, Feinberg AW. Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture. Biomark Insights 2015;10:71-6. [PMID: 26052225 DOI: 10.4137/BMI.S20050] [Cited by in Crossref: 11] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
75 Chen A, Ting S, Seow J, Reuveny S, Oh S. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res Ther 2014;5:12. [PMID: 24444355 DOI: 10.1186/scrt401] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
76 Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A. 2012;109:E1848-E1857. [PMID: 22645348 DOI: 10.1073/pnas.1200250109] [Cited by in Crossref: 941] [Cited by in F6Publishing: 812] [Article Influence: 104.6] [Reference Citation Analysis]
77 Lee CS, Cho HJ, Lee JW, Son H, Chai J, Kim HS. Adhesion GPCR Latrophilin-2 Specifies Cardiac Lineage Commitment through CDK5, Src, and P38MAPK. Stem Cell Reports 2021;16:868-82. [PMID: 33798451 DOI: 10.1016/j.stemcr.2021.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Zwi-dantsis L, Gepstein L. Induced pluripotent stem cells for cardiac repair. Cell Mol Life Sci 2012;69:3285-99. [DOI: 10.1007/s00018-012-1078-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
79 Plowright AT, Engkvist O, Gill A, Knerr L, Wang QD. Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents. Angew Chem Int Ed Engl. 2014;53:4056-4075. [PMID: 24470316 DOI: 10.1002/anie.201307034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
80 Ting S, Chen A, Reuveny S, Oh S. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures. Stem Cell Res. 2014;13:202-213. [PMID: 25043964 DOI: 10.1016/j.scr.2014.06.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
81 Braam SR, Nauw R, Ward-van Oostwaard D, Mummery C, Passier R. Inhibition of ROCK improves survival of human embryonic stem cell-derived cardiomyocytes after dissociation. Ann N Y Acad Sci 2010;1188:52-7. [PMID: 20201886 DOI: 10.1111/j.1749-6632.2009.05083.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
82 David R, Franz WM. From pluripotency to distinct cardiomyocyte subtypes. Physiology (Bethesda) 2012;27:119-29. [PMID: 22689787 DOI: 10.1152/physiol.00044.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
83 Yook J, Kim M, Son MJ, Lee S, Nam Y, Han Y, Cho YS. Combinatorial Activin Receptor-Like Kinase/Smad and Basic Fibroblast Growth Factor Signals Stimulate the Differentiation of Human Embryonic Stem Cells into the Cardiac Lineage. Stem Cells and Development 2011;20:1479-90. [DOI: 10.1089/scd.2010.0392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
84 Ting S, Liew SJ, Japson F, Shang F, Chong WK, Reuveny S, Tham JY, Li X, Oh S. Time‐resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays. Biotechnology Journal 2014;9:675-83. [DOI: 10.1002/biot.201300262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
85 Mehta A, Shim W. Cardiac stem cell therapy: stemness or commitment? Cell Transplant 2013;22:1-14. [PMID: 22943934 DOI: 10.3727/096368912X653282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
86 Kempf H, Andree B, Zweigerdt R. Large-scale production of human pluripotent stem cell derived cardiomyocytes. Adv Drug Deliv Rev 2016;96:18-30. [PMID: 26658242 DOI: 10.1016/j.addr.2015.11.016] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
87 Jiang B, Yan L, Shamul JG, Hakun M, He X. Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering. Adv Ther (Weinh) 2020;3:1900182. [PMID: 33665356 DOI: 10.1002/adtp.201900182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
88 Wei H, Zhang G, Qiu S, Lu J, Sheng J, Manasi, Tan G, Wong P, Gan SU, Shim W. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes. PLoS One 2012;7:e50641. [PMID: 23226343 DOI: 10.1371/journal.pone.0050641] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
89 Jameel MN, Zhang J. Stem cell therapy for ischemic heart disease. Antioxid Redox Signal 2010;13:1879-97. [PMID: 20687781 DOI: 10.1089/ars.2010.3434] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
90 Habib M, Caspi O, Gepstein L. Human embryonic stem cells for cardiomyogenesis. J Mol Cell Cardiol 2008;45:462-74. [PMID: 18775434 DOI: 10.1016/j.yjmcc.2008.08.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
91 Zhang X, Shen MR, Xu ZD, Hu Z, Chen C, Chi YL, Kong ZD, Li ZF, Li XT, Guo SL, Xiong SH, Zhang CS. Cardiomyocyte differentiation induced in cardiac progenitor cells by cardiac fibroblast-conditioned medium. Exp Biol Med (Maywood) 2014;239:628-37. [PMID: 24676907 DOI: 10.1177/1535370214525323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
92 Földes G, Mioulane M, Wright JS, Liu AQ, Novak P, Merkely B, Gorelik J, Schneider MD, Ali NN, Harding SE. Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J Mol Cell Cardiol. 2011;50:367-376. [PMID: 21047517 DOI: 10.1016/j.yjmcc.2010.10.029] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
93 Walsh KB. Targeting cardiac potassium channels for state-of-the-art drug discovery. Expert Opin Drug Discov 2015;10:157-69. [PMID: 25400064 DOI: 10.1517/17460441.2015.983471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
94 Doyle MJ, Lohr JL, Chapman CS, Koyano-Nakagawa N, Garry MG, Garry DJ. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease. Stem Cell Rev Rep 2015;11:710-27. [PMID: 26085192 DOI: 10.1007/s12015-015-9596-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
95 Pawani H, Nagvenkar P, Pethe P, Bhartiya D. Differentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors. In Vitro Cell Dev Biol Anim 2013;49:82-93. [PMID: 23288411 DOI: 10.1007/s11626-012-9558-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
96 Ramachandra CJ, Mehta A, Wong P, Shim W. ErbB4 Activated p38γ MAPK Isoform Mediates Early Cardiogenesis Through NKx2.5 in Human Pluripotent Stem Cells: ErbB4-p38γ Signaling and Cardiogenesis. Stem Cells 2016;34:288-98. [DOI: 10.1002/stem.2223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
97 Hudson J, Titmarsh D, Hidalgo A, Wolvetang E, Cooper-White J. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev 2012;21:1513-23. [PMID: 21933026 DOI: 10.1089/scd.2011.0254] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
98 Schwanke K, Merkert S, Kempf H, Hartung S, Jara-Avaca M, Templin C, Göhring G, Haverich A, Martin U, Zweigerdt R. Fast and efficient multitransgenic modification of human pluripotent stem cells. Hum Gene Ther Methods 2014;25:136-53. [PMID: 24483184 DOI: 10.1089/hgtb.2012.248] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
99 Abbey D, Seshagiri PB. Ascorbic acid-mediated enhanced cardiomyocyte differentiation of mouse ES-cells involves interplay of DNA methylation and multiple-signals. Differentiation 2017;96:1-14. [PMID: 28554048 DOI: 10.1016/j.diff.2017.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
100 Abou-Saleh H, Zouein FA, El-Yazbi A, Sanoudou D, Raynaud C, Rao C, Pintus G, Dehaini H, Eid AH. The march of pluripotent stem cells in cardiovascular regenerative medicine. Stem Cell Res Ther 2018;9:201. [PMID: 30053890 DOI: 10.1186/s13287-018-0947-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
101 Jin G, Palecek SP. Inductive factors for generation of pluripotent stem cell-derived cardiomyocytes. Engineering Strategies for Regenerative Medicine. Elsevier; 2020. pp. 177-242. [DOI: 10.1016/b978-0-12-816221-7.00006-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol. 2012;52:1203-1212. [PMID: 22484618 DOI: 10.1016/j.yjmcc.2012.03.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
103 Yeo HC, Ting S, Brena RM, Koh G, Chen A, Toh SQ, Lim YM, Oh SK, Lee DY. Genome-Wide Transcriptome and Binding Sites Analyses Identify Early FOX Expressions for Enhancing Cardiomyogenesis Efficiency of hESC Cultures. Sci Rep 2016;6:31068. [PMID: 27501774 DOI: 10.1038/srep31068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
104 Moon SH, Ban K, Kim C, Kim SS, Byun J, Song MK, Park IH, Yu SP, Yoon YS. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells. Int J Cardiol 2013;168:41-52. [PMID: 23044428 DOI: 10.1016/j.ijcard.2012.09.077] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
105 Shiba Y, Hauch KD, Laflamme MA. Cardiac applications for human pluripotent stem cells. Curr Pharm Des 2009;15:2791-806. [PMID: 19689350 DOI: 10.2174/138161209788923804] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
106 Sison-young R, Kia R, Heslop J, Kelly L, Rowe C, Cross M, Kitteringham N, Hanley N, Park B, Goldring C. Human Pluripotent Stem Cells for Modeling Toxicity. Current Concepts in Drug Metabolism and Toxicology. Elsevier; 2012. pp. 207-56. [DOI: 10.1016/b978-0-12-398339-8.00006-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
107 Rajamohan D, Matsa E, Kalra S, Crutchley J, Patel A, George V, Denning C. Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays. 2013;35:281-298. [PMID: 22886688 DOI: 10.1002/bies.201200053] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 8.1] [Reference Citation Analysis]
108 Zweigerdt R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 2009;114:201-35. [PMID: 19513633 DOI: 10.1007/10_2008_27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
109 Jonsson MK, van Veen TA, Goumans MJ, Vos MA, Duker G, Sartipy P. Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes. Expert Opin Drug Discov 2009;4:357-72. [PMID: 23485039 DOI: 10.1517/17460440902794912] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
110 Dambrot C, Passier R, Atsma D, Mummery CL. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem J 2011;434:25-35. [PMID: 21269276 DOI: 10.1042/BJ20101707] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
111 Zhang XZ. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules. Reprod Biomed Online 2010;21:26-36. [PMID: 20462797 DOI: 10.1016/j.rbmo.2010.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
112 Lecina M, Ting S, Choo A, Reuveny S, Oh S. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods. 2010;16:1609-1619. [PMID: 20590381 DOI: 10.1089/ten.tec.2010.0104] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
113 Nury D, Neri T, Pucéat M. Human embryonic stem cells and cardiac cell fate. J Cell Physiol 2009;218:455-9. [PMID: 19006174 DOI: 10.1002/jcp.21631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
114 Mandenius C, Steel D, Noor F, Meyer T, Heinzle E, Asp J, Arain S, Kraushaar U, Bremer S, Class R, Sartipy P. Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review: Cardiotoxicity testing using derived stem cells. J Appl Toxicol 2011;31:191-205. [DOI: 10.1002/jat.1663] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
115 Zhang J, Guo F, Wu H, Wei J, Xian M, Fan F, Tang S, Zhao Y, Zhang Y, Li D, Yang H. Yixin-Shu facilitated cardiac-like differentiation of mesenchymal stem cells in vitro. RSC Adv 2018;8:10032-9. [DOI: 10.1039/c7ra13326j] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
116 Tiburcy M, Hudson JE, Balfanz P, Schlick S, Meyer T, Chang Liao ML, Levent E, Raad F, Zeidler S, Wingender E, Riegler J, Wang M, Gold JD, Kehat I, Wettwer E, Ravens U, Dierickx P, van Laake LW, Goumans MJ, Khadjeh S, Toischer K, Hasenfuss G, Couture LA, Unger A, Linke WA, Araki T, Neel B, Keller G, Gepstein L, Wu JC, Zimmermann WH. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. Circulation. 2017;135:1832-1847. [PMID: 28167635 DOI: 10.1161/circulationaha.116.024145] [Cited by in Crossref: 267] [Cited by in F6Publishing: 146] [Article Influence: 66.8] [Reference Citation Analysis]
117 Phillips BW, Crook JM. Pluripotent Human Stem Cells: A Novel Tool in Drug Discovery. BioDrugs 2010;24:99-108. [DOI: 10.2165/11532270-000000000-00000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
118 Lian X, Zhang J, Zhu K, Kamp TJ, Palecek SP. Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells 2013;31:447-57. [PMID: 23193013 DOI: 10.1002/stem.1289] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
119 Haraguchi Y, Shimizu T, Yamato M, Okano T. Concise review: cell therapy and tissue engineering for cardiovascular disease. Stem Cells Transl Med 2012;1:136-41. [PMID: 23197760 DOI: 10.5966/sctm.2012-0030] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
120 Ou DB, He Y, Chen R, Teng JW, Wang HT, Zeng D, Liu XT, Ding L, Huang JY, Zheng QS. Three-dimensional co-culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes. J Cell Biochem 2011;112:3555-62. [PMID: 21780160 DOI: 10.1002/jcb.23283] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
121 Kehoe DE, Jing D, Lock LT, Tzanakakis ES. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A. 2010;16:405-421. [PMID: 19739936 DOI: 10.1089/ten.tea.2009.0454] [Cited by in Crossref: 184] [Cited by in F6Publishing: 151] [Article Influence: 16.7] [Reference Citation Analysis]
122 Lewandowski J, Kolanowski TJ, Kurpisz M. Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. J Tissue Eng Regen Med 2017;11:1658-74. [PMID: 26777594 DOI: 10.1002/term.2117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
123 Park M, Yoon YS. Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 2018;48:974-88. [PMID: 30334384 DOI: 10.4070/kcj.2018.0312] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
124 Greuel S, Hanci G, Böhme M, Miki T, Schubert F, Sittinger M, Mandenius CF, Zeilinger K, Freyer N. Effect of inoculum density on human-induced pluripotent stem cell expansion in 3D bioreactors. Cell Prolif 2019;52:e12604. [PMID: 31069891 DOI: 10.1111/cpr.12604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
125 Young DA, DeQuach JA, Christman KL. Human cardiomyogenesis and the need for systems biology analysis. Wiley Interdiscip Rev Syst Biol Med 2011;3:666-80. [PMID: 21197666 DOI: 10.1002/wsbm.141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
126 Hartung S, Schwanke K, Haase A, David R, Franz WM, Martin U, Zweigerdt R. Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev 2013;22:1112-25. [PMID: 23157212 DOI: 10.1089/scd.2012.0351] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
127 Ting S, Lecina M, Reuveny S, Oh S. Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures. Curr Protoc Stem Cell Biol. 2012;Chapter 1:Unit1D.7. [PMID: 22605644 DOI: 10.1002/9780470151808.sc01d07s21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
128 Stacey GN, Coecke S, Price A, Healy L, Jennings P, Wilmes A, Pinset C, Ingelman-sundberg M, Louisse J, Haupt S, Kidd D, Robitski A, Jahnke H, Lemaitre G, Myatt G. Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing. In: Eskes C, Whelan M, editors. Validation of Alternative Methods for Toxicity Testing. Cham: Springer International Publishing; 2016. pp. 259-97. [DOI: 10.1007/978-3-319-33826-2_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
129 Savla JJ, Nelson BC, Perry CN, Adler ED. Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease. Journal of the American College of Cardiology 2014;64:512-9. [DOI: 10.1016/j.jacc.2014.05.038] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
130 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol. 2012;110:178-195. [PMID: 22958937 DOI: 10.1016/j.pbiomolbio.2012.07.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
131 Soong PL, Tiburcy M, Zimmermann WH. Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle. Curr Protoc Cell Biol 2012;Chapter 23:Unit23.8. [PMID: 23129117 DOI: 10.1002/0471143030.cb2308s55] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
132 Földes G, Harding SE, Ali NN. Cardiomyocytes from embryonic stem cells: towards human therapy. Expert Opinion on Biological Therapy 2008;8:1473-83. [DOI: 10.1517/14712598.8.10.1473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
133 Verma V, Purnamawati K, Manasi, Shim W. Steering signal transduction pathway towards cardiac lineage from human pluripotent stem cells: A review. Cellular Signalling 2013;25:1096-107. [DOI: 10.1016/j.cellsig.2013.01.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
134 Bernstein HS, Srivastava D. Stem cell therapy for cardiac disease. Pediatr Res 2012;71:491-9. [DOI: 10.1038/pr.2011.61] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 8.4] [Reference Citation Analysis]
135 Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS, Yeghiazarians Y. Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy. 2010;12:807-817. [PMID: 20586669 DOI: 10.3109/14653249.2010.491821] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
136 Denning C, Anderson D. Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity. Drug Discovery Today: Therapeutic Strategies 2008;5:223-32. [DOI: 10.1016/j.ddstr.2008.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
137 Parrotta EI, Scalise S, Scaramuzzino L, Cuda G. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine. Int J Mol Sci 2019;20:E5760. [PMID: 31744081 DOI: 10.3390/ijms20225760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
138 Yang C, Al-Aama J, Stojkovic M, Keavney B, Trafford A, Lako M, Armstrong L. Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells. Stem Cells. 2015;33:2643-2651. [PMID: 26033645 DOI: 10.1002/stem.2070] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
139 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
140 Pekkanen-Mattila M, Pelto-Huikko M, Kujala V, Suuronen R, Skottman H, Aalto-Setälä K, Kerkelä E. Spatial and temporal expression pattern of germ layer markers during human embryonic stem cell differentiation in embryoid bodies. Histochem Cell Biol 2010;133:595-606. [PMID: 20369364 DOI: 10.1007/s00418-010-0689-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
141 Yan L, Jia Z, Cui J, Yang H, Yang H, Zhang Y, Zhou C. Beta-adrenergic signals regulate cardiac differentiation of mouse embryonic stem cells via mitogen-activated protein kinase pathways. Dev Growth Differ 2011;53:772-9. [PMID: 21711454 DOI: 10.1111/j.1440-169X.2011.01284.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
142 Chakraborty S, Kang B, Huang F, Guo YL. Mouse embryonic stem cells lacking p38alpha and p38delta can differentiate to endothelial cells, smooth muscle cells, and epithelial cells. Differentiation 2009;78:143-50. [PMID: 19539422 DOI: 10.1016/j.diff.2009.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
143 Malandraki-Miller S, Lopez CA, Al-Siddiqi H, Carr CA. Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes? Front Cardiovasc Med 2018;5:119. [PMID: 30283788 DOI: 10.3389/fcvm.2018.00119] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
144 Braam SR, Tertoolen L, van de Stolpe A, Meyer T, Passier R, Mummery CL. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 2010;4:107-116. [PMID: 20034863 DOI: 10.1016/j.scr.2009.11.004] [Cited by in Crossref: 271] [Cited by in F6Publishing: 231] [Article Influence: 22.6] [Reference Citation Analysis]
145 Mehta A, Ramachandra CJ, Sequiera GL, Sudibyo Y, Nandihalli M, Yong PJ, Koh CH, Shim W. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014;1843:2394-402. [DOI: 10.1016/j.bbamcr.2014.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
146 Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovascular Research 2011;91:577-86. [DOI: 10.1093/cvr/cvr132] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
147 Yeghiazarians Y, Gaur M, Zhang Y, Sievers RE, Ritner C, Prasad M, Boyle A, Bernstein HS. Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition. Cytotherapy 2012;14:223-31. [PMID: 22040108 DOI: 10.3109/14653249.2011.623690] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
148 Plowright AT, Engkvist O, Gill A, Knerr L, Wang Q. Herzregeneration: Chancen und Aufgaben für die Wirkstoff-Forschung mit neuartigen chemischen und therapeutischen Methoden oder Agentien. Angew Chem 2014;126:4138-59. [DOI: 10.1002/ange.201307034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
149 Jara Avaca M, Gruh I. Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application. Adv Biochem Eng Biotechnol. 2018;163:117-146. [PMID: 29218360 DOI: 10.1007/10_2017_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Acimovic I, Vilotic A, Pesl M, Lacampagne A, Dvorak P, Rotrekl V, Meli AC. Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int 2014;2014:512831. [PMID: 24800237 DOI: 10.1155/2014/512831] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
151 Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014;11:855-860. [PMID: 24930130 DOI: 10.1038/nmeth.2999] [Cited by in Crossref: 824] [Cited by in F6Publishing: 669] [Article Influence: 117.7] [Reference Citation Analysis]
152 David R, Schwarz F, Rimmbach C, Nathan P, Jung J, Brenner C, Jarsch V, Stieber J, Franz W. Selection of a common multipotent cardiovascular stem cell using the 3.4-kb MesP1 promoter fragment. Basic Res Cardiol 2013;108. [DOI: 10.1007/s00395-012-0312-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]